Nuveen Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $494K | Hold |
270,184
| – | – | ﹤0.01% | 2989 |
|
|
2024
Q3 | $459K | Hold |
270,184
| – | – | ﹤0.01% | 3044 |
|
|
2024
Q2 | $370K | Sell |
270,184
-409,742
| -60% | -$561K | ﹤0.01% | 3090 |
|
|
2024
Q1 | $2.55M | Buy |
679,926
+14,121
| +2% | +$53K | ﹤0.01% | 2286 |
|
|
2023
Q4 | $6.53M | Buy |
665,805
+7,057
| +1% | +$69.2K | ﹤0.01% | 1826 |
|
|
2023
Q3 | $5.5M | Sell |
658,748
-4,281
| -0.6% | -$35.7K | ﹤0.01% | 1819 |
|
|
2023
Q2 | $8.82M | Buy |
663,029
+5,231
| +0.8% | +$69.6K | ﹤0.01% | 1586 |
|
|
2023
Q1 | $7.62M | Sell |
657,798
-47,309
| -7% | -$548K | ﹤0.01% | 1648 |
|
|
2022
Q4 | $5.77M | Sell |
705,107
-167,530
| -19% | -$1.37M | ﹤0.01% | 1829 |
|
|
2022
Q3 | $5.07M | Sell |
872,637
-10,278
| -1% | -$59.7K | ﹤0.01% | 1894 |
|
|
2022
Q2 | $3.9M | Sell |
882,915
-187,388
| -18% | -$828K | ﹤0.01% | 2109 |
|
|
2022
Q1 | $10.6M | Sell |
1,070,303
-102,415
| -9% | -$1.02M | ﹤0.01% | 1598 |
|
|
2021
Q4 | $24M | Sell |
1,172,718
-76,841
| -6% | -$1.58M | 0.01% | 1108 |
|
|
2021
Q3 | $36.8M | Sell |
1,249,559
-29,020
| -2% | -$854K | 0.01% | 852 |
|
|
2021
Q2 | $44.7M | Buy |
1,278,579
+160,159
| +14% | +$5.6M | 0.01% | 809 |
|
|
2021
Q1 | $37.3M | Buy |
1,118,420
+280,568
| +33% | +$9.35M | 0.01% | 894 |
|
|
2020
Q4 | $21.7M | Buy |
837,852
+175,450
| +26% | +$4.55M | 0.01% | 1207 |
|
|
2020
Q3 | $6.54M | Buy |
662,402
+101,446
| +18% | +$1M | ﹤0.01% | 1781 |
|
|
2020
Q2 | $1.94M | Sell |
560,956
-12,128
| -2% | -$41.8K | ﹤0.01% | 2352 |
|
|
2020
Q1 | $1.75M | Buy |
573,084
+19,593
| +4% | +$59.9K | ﹤0.01% | 2251 |
|
|
2019
Q4 | $2.85M | Sell |
553,491
-689
| -0.1% | -$3.54K | ﹤0.01% | 2269 |
|
|
2019
Q3 | $2.86M | Buy |
554,180
+12,336
| +2% | +$63.7K | ﹤0.01% | 2244 |
|
|
2019
Q2 | $3.28M | Buy |
+541,844
| New | +$3.28M | ﹤0.01% | 2206 |
|